← Evidence map

ArticleClinical pharmacology and therapeutics2026

Carbon Footprint of Antibody-Based Drugs and Biologics Using Hybrid Life Cycle Assessment.

Sébastien Taillemite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42092334